Patents by Inventor C. Mark Eppler

C. Mark Eppler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Mu-subtype opioid receptor
    Patent number: 6225080
    Abstract: Isolated DNA encoding mu-subtype opioid receptor polypeptides is provided. Recombinant cloning vectors which include this DNA and cells that incorporate these vectors are also provided. Methods for producing these receptors and purifying them from native and heterologous sources are also disclosed.
    Type: Grant
    Filed: April 28, 1995
    Date of Patent: May 1, 2001
    Inventors: George R. Uhl, C. Mark Eppler, Jai-Bel Wang
  • Method of detecting expression of proteins closely related to opioid receptors
    Patent number: 5866324
    Abstract: Isolated DNAs encoding opiorph receptor polypeptides are provided. Recombinant cloning vectors which include these DNA sequences and cells which include these vectors are also provided. Methods for detecting the expression, in a tissue, of mRNA encoding a polypeptide encoded by this DNA are encompassed as well as methods for producing these polypeptides. These isolated polypeptides and antibodies to these polypeptides are also contemplated.
    Type: Grant
    Filed: May 30, 1995
    Date of Patent: February 2, 1999
    Assignee: American Cyanamid Company
    Inventors: C. Mark Eppler, Bradley A. Ozenberger, Jeffrey D. Hulmes